Ruminant BioTech
Latest round
- Series A
Last raised
- Nov 2025
Total raised
- $9.5M
Investors
- 4
About Ruminant BioTech
Based in Auckland, New Zealand, and founded in 2021, Ruminant BioTech is a company focused on mitigating methane emissions from ruminant animals. The company’s primary product is a slow-release bolus designed for use in cows. This device remains in the animal’s stomach for up to six months, reducing methane emissions during that time. Clinical trials have demonstrated that the bolus can achieve over 70% methane reduction within three months and helps in addressing greenhouse gas emissions from livestock.
Who invested in Ruminant BioTech
4 investors across 1 round
See all investors in Ruminant BioTech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 26, 2025
Amount
$9.5M
Investors
Questions about Ruminant BioTech
Who invested in Ruminant BioTech?
Ruminant BioTech has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ruminant BioTech raised?
Ruminant BioTech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ruminant BioTech last raise money?
Ruminant BioTech's most recent round on record is a Series A, in Nov 2025.
What does Ruminant BioTech do?
Based in Auckland, New Zealand, and founded in 2021, Ruminant BioTech is a company focused on mitigating methane emissions from ruminant animals.
Where is Ruminant BioTech headquartered?
Ruminant BioTech is headquartered in Auckland, New Zealand.
Which VCs invest in companies like Ruminant BioTech?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at Ruminant BioTech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ruminant BioTech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.